Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$195.32	$14,280,742,110
	22,362,850	$195.32	$4,367,911,862
	17,233,668	$195.32	$3,366,080,034
	14,567,176	$195.32	$2,845,260,817
	9,033,726	$195.32	$1,764,467,363
	8,998,338	$195.32	$1,757,555,379
	8,322,140	$195.32	$1,625,480,385
	8,009,729	$195.32	$1,564,460,269
	7,619,135	$195.32	$1,488,169,449
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Feb 12, 2016 03:06PM Form SC 13G IMMUNOGEN INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:42PM Form SC 13G CONNECTURE INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:40PM Form SC 13G/A CERUS CORP Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:37PM Form SC 13G ASSEMBLY BIOSCIENCES, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:34PM Form SC 13G/A ARRAY BIOPHARMA INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:29PM Form SC 13G/A ARQULE INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:26PM Form SC 13G/A AFFYMETRIX INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:23PM Form SC 13G ACHILLION PHARMACEUTICAL Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:14PM Form SC 13G GLAUKOS Corp Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 05:09PM Form SC 13G/A XENOPORT INC Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:55PM Form SC 13G/A Wright Medical Group Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:52PM Form SC 13G/A SINOVAC BIOTECH LTD Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:50PM Form SC 13G/A Sientra, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:44PM Form SC 13G/A ProQR Therapeutics N.V. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:42PM Form SC 13G PUMA BIOTECHNOLOGY, INC. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:39PM Form SC 13G Ophthotech Corp. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:37PM Form SC 13G/A InspireMD, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:35PM Form SC 13G/A NEUROCRINE BIOSCIENCES Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:31PM Form SC 13G MAGELLAN HEALTH INC Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:31PM Form SC 13G/A Mirati Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:29PM Form SC 13G/A MEI Pharma, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:28PM Form SC 13G/A MOLINA HEALTHCARE INC Filed by: ORBIMED ADVISORS LLC
Jan 11, 2016 08:00AM Adimab Provides Update on Recent Partnerships and Milestones
Jan 6, 2016 06:00AM NextCure, Inc., New Immuno-Oncology Firm, Announces $67 Million Series A Financing
Dec 24, 2015 08:43AM OrbiMed Advisors Sells Nearly 500K Shares of RELYPSA (RLYP); Still Has Significant 17.75% Stake
Dec 24, 2015 08:36AM Form SC 13D/A Relypsa Inc Filed by: ORBIMED ADVISORS LLC
Dec 23, 2015 05:06PM Form 4 Relypsa Inc For: Dec 21 Filed by: ORBIMED ADVISORS LLC
Dec 16, 2015 01:01AM Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act
Dec 14, 2015 06:00AM Viralytics Completes $28 million Placement -- SPP to Follow
Nov 30, 2015 06:56PM Form 4 Otonomy, Inc. For: Nov 25 Filed by: ORBIMED ADVISORS LLC
Nov 25, 2015 02:26PM Form SC 13D/A Otonomy, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 20, 2015 11:17AM Form SC 13D/A Ascendis Pharma A/S Filed by: ORBIMED ADVISORS LLC
Nov 19, 2015 03:58PM Form SC 13D/A Loxo Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 19, 2015 11:58AM Neurostimulation Established as a Treatment Option for Sleep Apnea Patients Who Do Not Tolerate CPAP
Nov 19, 2015 08:20AM Conference Forum's Immuno-Oncology 360° Announces the Support of Key Partnerships to Present Multiple Views to Advance IO as a Standard of Cancer Treatment
Nov 19, 2015 06:01AM Form SC 13D/A Adaptimmune Therapeutics Filed by: ORBIMED ADVISORS LLC
Nov 13, 2015 04:17PM Form 13F-HR ORBIMED ADVISORS LLC For: Sep 30
Nov 11, 2015 04:27PM Xtant Medical Holdings, Inc. Reports Third Quarter 2015 Results
Nov 10, 2015 09:00AM Inspire Medical Systems to Present at Three Upcoming Investor Conferences
Nov 6, 2015 04:35PM Form SC 13D Dimension Therapeutics, Filed by: ORBIMED ADVISORS LLC
Oct 30, 2015 05:14PM Form SC 13D/A Relypsa Inc Filed by: ORBIMED ADVISORS LLC
Oct 20, 2015 02:25PM Healthbox Returns to Israel to Accelerate Entrepreneurs' Access to the US Market
Oct 14, 2015 03:50PM EY and SolomonEdwards honor the 2015 Venture Capital Award of Excellence winners
Oct 14, 2015 08:00AM The Galien Foundation Announces Partnership with Business France to Foster US-France Life Sciences Innovation via MedStartUp Program
Oct 13, 2015 04:02PM Form 4 Sientra, Inc. For: Oct 12 Filed by: ORBIMED ADVISORS LLC
Oct 9, 2015 07:50PM Form 4 Sientra, Inc. For: Oct 07 Filed by: ORBIMED ADVISORS LLC
Oct 6, 2015 07:34PM Form 4 Sientra, Inc. For: Oct 02 Filed by: ORBIMED ADVISORS LLC
Oct 6, 2015 01:04PM Onxeo Announces Evolution in the Board of Directors
Oct 5, 2015 03:23PM TytoCare Hires Jeff Cutler to Lead Commercial Launch of its Remote Home Exam Platform
Oct 2, 2015 05:26PM Form SC 13D Nabriva Therapeutics AG Filed by: ORBIMED ADVISORS LLC

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed